We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 236

China FDA announces key appointments and restructuring plan

  • Ropes & Gray LLP
  • -
  • China
  • -
  • May 21 2013

Following its recent re-elevation to the ministry level and the appointment of a new Commissioner in March, Mr. Yong Zhang, former Director of the

China publishes revised good supply practice (GSP) standards for pharmaceutical products

  • Clifford Chance LLP
  • -
  • China
  • -
  • May 20 2013

After several years of drafting and three rounds of public consultation, the Ministry of Health has at last published the revised Good Supply

The PRC Mental Health Law came into force

  • King & Wood Mallesons
  • -
  • China
  • -
  • May 20 2013

The PRC Mental Health Law (the "Mental Health Law") came into force on May 1, 2013. For the purpose of the Mental Health Law, "mental disorders"

More certainty, less discretion proposed new rules on administrative penalty over drug and medical equipment industry

  • King & Wood Mallesons
  • -
  • China
  • -
  • May 10 2013

On 19 September 2012, SFDA released the Rules on Imposing Administrative Penalties for Drugs and Medical Equipment (Consultative Draft) (the "Draft"

Engineered avian and swine flu hybrids raise concerns about mammal-to-mammal transmission

  • Shook Hardy & Bacon LLP
  • -
  • China
  • -
  • May 10 2013

Chinese scientists investigating the spread of airborne influenzas have reportedly combined genetic material from avian (H5N1) and swine (H1N1) flu

RDPAC code of practice 2012

  • King & Wood Mallesons
  • -
  • China
  • -
  • May 9 2013

Although the existing laws and regulations already establish certain rules and general principles for product promotional activities by

New essential drugs list issued by Ministry of Health

  • HFG Intellectual Property Consulting Ltd
  • -
  • China
  • -
  • April 30 2013

On 19th March, PRC Ministry of Health issued a list of essential medicine made by 317 kinds of chemical medicines and biological products and 203

CFDA seeks public comment on Special Approval Procedures for Innovative Medical Devices

  • Reed Smith LLP
  • -
  • China
  • -
  • April 26 2013

China Food and Drug Administration ("CFDA," previously known as "SFDA") issued a draft Notice on Soliciting Public Comments on the Special Approval

CFDA allows manufacturers to confirm medical device classes

  • Reed Smith LLP
  • -
  • China
  • -
  • April 26 2013

In late March 2013, CFDA issued a Notice Concerning Further Improvement to Defining Classification of Medical Devices. The Notice allows the

The promotion of private healthcare services- a challenge or an opportunity?

  • King & Wood Mallesons
  • -
  • China
  • -
  • April 18 2013

To address China's aging population issue as well as its need to improve access to healthcare in rural areas, healthcare reform has become a priority